NICE Clinical Knowledge Summary Vitamin B12 Deficiency
In clinical use, the most commonly reported side effects are: Mild injection site redness or swelling (resolves within hours) Occasional lightheadedness following injection (less common, position-dependent) Temporary nausea with oral administration in some patients Who should not use BPC-157: Patients with active cancer or a history of cancer should discuss BPC-157 carefully with their oncologist before use angiogenic peptides theoretically could support tumor vascularity, though no evidence of this has been demonstrated in animals
What is Glutathione (GSH) Liposomal
The standard treatment for overdose is N-acetyl-cysteine (NAC), which is given to stimulate the production of glutathione
This is particularly problematic for Vitamin B12, which requires a specific protein called intrinsic factor in the stomach to be absorbed properly
Regulatory Update (April 2026): DSIP (also referred to as Emideltide) is one of seven peptides scheduled for FDA Pharmacy Compounding Advisory Committee review on July 24, 2026
